NCX 701

Drug Profile

NCX 701

Alternative Names: nitro-paracetamol; NO-paracetamol

Latest Information Update: 31 Jul 2012

Price : $50

At a glance

  • Originator NicOx
  • Class Acetanilides; Analgesics; Anti-inflammatories; Nitrates; Small molecules
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 27 Jul 2012 Discontinued - Phase-II for Pain in USA (PO)
  • 04 Aug 2010 NCX 701 is available for licensing worldwide (http://www.nicox.com)
  • 04 Aug 2010 NicOx to close its headquarters in the USA on August 31, 2010
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top